These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7600670)

  • 1. Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms.
    Gordon I; Weizman R; Rosenne E; Rehavi M
    Brain Res Dev Brain Res; 1995 Apr; 85(2):225-8. PubMed ID: 7600670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood.
    Moll GH; Mehnert C; Wicker M; Bock N; Rothenberger A; Rüther E; Huether G
    Brain Res Dev Brain Res; 2000 Feb; 119(2):251-7. PubMed ID: 10675775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of amygdaloid kindling on striatal dopaminergic terminals.
    Gordon I; Mintz M; Rosenne E; Rehavi M
    Brain Res Bull; 1995; 36(3):235-9. PubMed ID: 7697376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in function and ultrastructure of striatal dopaminergic terminals that regenerate following partial lesions of the SNpc.
    Stanic D; Parish CL; Zhu WM; Krstew EV; Lawrence AJ; Drago J; Finkelstein DI; Horne MK
    J Neurochem; 2003 Jul; 86(2):329-43. PubMed ID: 12871574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain.
    Watanabe M; Nonaka R; Hagino Y; Kodama Y
    Neurosci Res; 1998 Feb; 30(2):135-44. PubMed ID: 9579647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological modulation of dopaminergic transmission in the rat striatum in vivo].
    Raevskiĭ KS; Gaĭnetdinov RR; Budygin EA; Mannisto P; Wightman M
    Ross Fiziol Zh Im I M Sechenova; 2000 Sep; 86(9):1152-9. PubMed ID: 11081220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of methylmercury on in vivo striatal dopamine release. Possible involvement of dopamine transporter.
    Faro LR; do Nascimento JL; Alfonso M; Durán R
    Neurochem Int; 2002 Apr; 40(5):455-65. PubMed ID: 11821154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
    Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of agents active in the presynaptic dopaminergic system on the striatal dopamine transporter.
    Gordon I; Weizman R; Rehavi M
    Eur J Pharmacol; 1996 Feb; 298(1):27-30. PubMed ID: 8867915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.
    Haycock JW; Becker L; Ang L; Furukawa Y; Hornykiewicz O; Kish SJ
    J Neurochem; 2003 Nov; 87(3):574-85. PubMed ID: 14535941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of metaphit on dopaminergic neurotransmission in rat striatal slices: involvement of the dopamine transporter and voltage-dependent sodium channel.
    Reith ME; Jacobson AE; Rice KC; Benuck M; Zimanyi I
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1188-96. PubMed ID: 1662274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1 enhances dopaminergic markers in the brain of aged rats.
    Goettl VM; Zhang H; Burrows AC; Wemlinger TA; Neff NH; Hadjiconstantinou M
    Exp Neurol; 2003 Oct; 183(2):665-72. PubMed ID: 14552908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
    Kula NS; Baldessarini RJ
    Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
    Lee CS; Samii A; Sossi V; Ruth TJ; Schulzer M; Holden JE; Wudel J; Pal PK; de la Fuente-Fernandez R; Calne DB; Stoessl AJ
    Ann Neurol; 2000 Apr; 47(4):493-503. PubMed ID: 10762161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
    Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
    Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
    Valchar M; Hanbauer I
    J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study.
    Balcioglu A; Zhang K; Tarazi FI
    Neuroscience; 2003; 119(4):1045-53. PubMed ID: 12831863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine release is impaired in a mouse model of DYT1 dystonia.
    Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
    J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.